Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab

NCT00636805 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
63
Enrollment
OTHER
Sponsor class

Stopped Study was halted early after 63 subjects were enrolled due to slow accrual.

Conditions

Interventions

Sponsor

Duke University

Collaborators